Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Feasibility and Acceptability of a New Personalised Form of Cognitive Remediation Therapy (pCRT) for People With Psychosis.

NCT03461432 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT03461432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03461432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Feasibility and Acceptability of a New Personalised Form of Cognitive Remediation Therapy (pCRT) for People With Psychosis.
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2018
Completion date
December 31, 2019
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia schizoaffective